Literature DB >> 8090081

Vibrio cholerae O139 Bengal possesses a capsular polysaccharide which may confer increased virulence.

A Weintraub1, G Widmalm, P E Jansson, M Jansson, K Hultenby, M J Albert.   

Abstract

A newly described Vibrio cholerae serogroup--O139 Bengal, the causative agent of the recent large epidemics of cholera-like disease in the Indian subcontinent and neighbouring countries--possesses a high molecular weight capsular polysaccharide (CPS) that can be visualized by electron microscopy and in composition differs from the lipopolysaccharide (LPS). The CPS and LPS can be separated from each other by a two-step extraction procedure, a phenol-water extraction in order to extract all polysaccharides from the bacterial suspension followed by a phenol-chloroform-petroleum ether (PCP) extraction. The CPS is mainly composed of 3,6-dideoxyhexose (abequose or colitose), quinovosamine and glucosamine. The LPS of the O139 Bengal strain appears to possess a short polysaccharide which contains glucose, galactose, glucosamine and heptose. Both the LPS and CPS are immunogenic. They react in an enzyme immunoassay with rabbit antibodies generated against whole heat-killed bacteria. By analogy with other capsulated bacteria, the possession of a capsule may confer increased virulence of O139 Bengal.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8090081     DOI: 10.1006/mpat.1994.1024

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  27 in total

1.  Cloning and sequencing of the genes downstream of the wbf gene cluster of Vibrio cholerae serogroup O139 and analysis of the junction genes in other serogroups.

Authors:  S Sozhamannan; Y K Deng; M Li; A Sulakvelidze; J B Kaper; J A Johnson; G B Nair; J G Morris
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

2.  PLASMID MEDIATED DRUG RESISTANCE IN VIBRIO CHOLERAE 0139 BENGAL.

Authors:  R N Misra; N K Debata; A Nagend; T S Hyder; V C Ohri
Journal:  Med J Armed Forces India       Date:  2017-06-26

3.  Isolation and characterization of rugose form of Vibrio cholerae O139 strain MO10.

Authors:  Y Mizunoe; S N Wai; A Takade; S I Yoshida
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

4.  Cloning and sequence of a region of Vibrio cholerae O139 Bengal and its use in PCR-based detection.

Authors:  S Falklind; M Stark; M J Albert; M Uhlén; J Lundeberg; A Weintraub
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

Review 5.  Vibrio cholerae O139 Bengal.

Authors:  M J Albert
Journal:  J Clin Microbiol       Date:  1994-10       Impact factor: 5.948

6.  Emergence and evolution of Vibrio cholerae O139.

Authors:  Shah M Faruque; David A Sack; R Bradley Sack; Rita R Colwell; Yoshifumi Takeda; G Balakrish Nair
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

7.  Structural and functional characterization of IS1358 from Vibrio cholerae.

Authors:  S Dumontier; P Trieu-Cuot; P Berche
Journal:  J Bacteriol       Date:  1998-12       Impact factor: 3.490

8.  The Vibrio cholerae O139 serogroup antigen includes an O-antigen capsule and lipopolysaccharide virulence determinants.

Authors:  M K Waldor; R Colwell; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-22       Impact factor: 11.205

Review 9.  Critical analysis of compositions and protective efficacies of oral killed cholera vaccines.

Authors:  Shahjahan Kabir
Journal:  Clin Vaccine Immunol       Date:  2014-07-23

10.  Vibrio cholerae O139 requires neither capsule nor LPS O side chain to grow inside Acanthamoeba castellanii.

Authors:  Hadi Abd; Amir Saeed; Andrej Weintraub; Gunnar Sandström
Journal:  J Med Microbiol       Date:  2009-01       Impact factor: 2.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.